BioCentury | Aug 22, 2006
Company News

4-Antibody names CEO, raises $4.9M

...series A round led by BioMedinvest and Life Science Partners. Existing investors Grazia Equity and Mulligan BioCapital...
BioCentury | Oct 17, 2005
Emerging Company Profile

Company Profile

...raised: E15.1 million ($18.5 million) Investors: Global Life Science Ventures; BioMedinvest AG; FNI Venture Capital; Mulligan BioCapital...
BioCentury | Sep 19, 2005
Financial News

Neuraxo raises EUR 12.8 million

...in a series A round led by Global Life Science Ventures and BioMedinvest. FNI and Mulligan BioCapital...
BioCentury | Mar 15, 2005
Financial News

Fibrex raises $10M

...round led by Global Life Sciences Ventures and Atlas Venture. Other investors included EMBL and Mulligan BioCapital...
BioCentury | Jan 12, 2004
Finance

Ebb & Flow

...a partner on its life science team. zur Hausen previously was a managing director at Mulligan BioCapital...
BioCentury | Aug 25, 2003
Top Story

Coley raises $30 million

...Christoph Schroder of JSB Partners will join Coley's board. Schroder sits on the board of Mulligan BioCapital...
BioCentury | Jul 14, 2003
Emerging Company Profile

Corporate Profile

...Funds raised: E29.7 million ($28.7 million) Investors: 3i, Bayern Kapital; BdW mbH; BioM AG; DVC; Mulligan BioCapital...
BioCentury | May 26, 2003
Finance

Ebb & Flow

...diseases. Including this round, 4SC has raised about E30 million ($35 million). Investors included 3i; Mulligan Biocapital...
BioCentury | May 21, 2003
Financial News

4SC raises EUR 9 million

...million ($10.4 million) in a private round. Investors included 3i Group; Deutsche Venture Capital DVC; Mulligan Biocapital...
BioCentury | Sep 23, 2002
Financial News

Cardion raises EUR11.5 million

...by TVM Techno Venture Management. Other inventors included DVC Deutsche Venture Capital; IKB Private Equity; Mulligan BioCapital...
Items per page:
1 - 10 of 12
BioCentury | Aug 22, 2006
Company News

4-Antibody names CEO, raises $4.9M

...series A round led by BioMedinvest and Life Science Partners. Existing investors Grazia Equity and Mulligan BioCapital...
BioCentury | Oct 17, 2005
Emerging Company Profile

Company Profile

...raised: E15.1 million ($18.5 million) Investors: Global Life Science Ventures; BioMedinvest AG; FNI Venture Capital; Mulligan BioCapital...
BioCentury | Sep 19, 2005
Financial News

Neuraxo raises EUR 12.8 million

...in a series A round led by Global Life Science Ventures and BioMedinvest. FNI and Mulligan BioCapital...
BioCentury | Mar 15, 2005
Financial News

Fibrex raises $10M

...round led by Global Life Sciences Ventures and Atlas Venture. Other investors included EMBL and Mulligan BioCapital...
BioCentury | Jan 12, 2004
Finance

Ebb & Flow

...a partner on its life science team. zur Hausen previously was a managing director at Mulligan BioCapital...
BioCentury | Aug 25, 2003
Top Story

Coley raises $30 million

...Christoph Schroder of JSB Partners will join Coley's board. Schroder sits on the board of Mulligan BioCapital...
BioCentury | Jul 14, 2003
Emerging Company Profile

Corporate Profile

...Funds raised: E29.7 million ($28.7 million) Investors: 3i, Bayern Kapital; BdW mbH; BioM AG; DVC; Mulligan BioCapital...
BioCentury | May 26, 2003
Finance

Ebb & Flow

...diseases. Including this round, 4SC has raised about E30 million ($35 million). Investors included 3i; Mulligan Biocapital...
BioCentury | May 21, 2003
Financial News

4SC raises EUR 9 million

...million ($10.4 million) in a private round. Investors included 3i Group; Deutsche Venture Capital DVC; Mulligan Biocapital...
BioCentury | Sep 23, 2002
Financial News

Cardion raises EUR11.5 million

...by TVM Techno Venture Management. Other inventors included DVC Deutsche Venture Capital; IKB Private Equity; Mulligan BioCapital...
Items per page:
1 - 10 of 12